Anlon Healthcare Subscription Day 1
Posted by : sachet | Wed Aug 27 2025
Here, Anlon Healthcare launched on 26th August 2025. The issue will be closed for bidding today, on 29th August 2025. The primary aim of Anlon Healthcare is to raise ₹121.03 crores from the market. Also, Anlon Healthcare has received an impressive level of subscription, which indicates that shares will be listed at an impeccable premium. Scroll down to check the Anlon Healthcare subscription and details.
Anlon Healthcare Details
| IPO Open Date | 26th August 2025 |
| Face Value | ₹10 per share |
| Price Band | ₹86 to 91 per share |
| Lot Size | 164 Shares |
| Issue Type | Bookbuilding IPO |
| Listing At | BSE and NSE |
| IPO Close Date | 29th August 2025 |
| Listing Date | 3rd September 2025 |
The price band for Anlon Healthcare has been prescribed as ₹86 to ₹91 per share, with a total of 1,33,00,000 shares issued. Let’s segregate the share quota fixed for different categories of investors.
| Categories | Shares Offered | % Shares offered |
| QIB Shares Offered | 99,75,000 | 0.00% |
| NII (HNI) Shares Offered | 19,95,000 | 15.00% |
| Retail Investors | 13,30,000 | 10.00% |
| Total Shares Offered | 1,33,00,000 | 100.00% |
Anlon Healthcare Subscription Status
As of now, Anlon Healthcare has been subscribed to 1.69 times. Of these, 8.99 times are subscribed by retail investors, 0.71 times by non-institutional investors, and 0.91 times by QII (Qualified Institutional Investors).
The healthy subscription status indicates that investors are expecting higher returns at the time of the Anlon Healthcare listing on 3rd September 2025. Anlon Healthcare also has a positive outlook behind the fresh issue of 1.33 crore shares to raise around Rs 121.03 crore.
Anlon Healthcare GMP Today
We know that higher subscriptions encourage grey market premiums for the IPOs. Let’s explore the Anlon Healthcare GMP for 26th August 2025.
The grey market premium for this IPO is 5.49% or Rs 5 per share. It indicates that the estimated listing price per share is Rs 96. Numerous factors played a pivotal role in this jump in Anlon Healthcare’s IPO GMP. These include higher subscriptions received, positive market sentiments, and investors’ positive attitude towards IPO.
About Anlon Healthcare Ltd.
Anlon Healthcare Limited is a chemical manufacturing company engaged in the manufacturing of high-purity advanced pharmaceutical intermediates, which serve as raw material/ key starting material in the manufacturing of active pharmaceutical ingredients. The company also undertakes API development, preparation, and filing of Drug Master File (DMF) in the Indian and global markets as per the pharmacopoeia requirements of customers and regulatory agencies. In addition to the manufacturing of Pharma Intermediates and APIs in accordance with various domestic and international standards, we have recently started undertaking custom manufacturing services for complex or novel chemical compounds, tailoring the manufacturing process to meet specific customer requirements, including producing chemicals with purity levels that exceed industry standards.
Financial Performance
Assess the financial performance of the company for the past three years to get an idea of the expectations for the Anlon Healthcare listing.
| Year Ended | 31st March 2025 (in cr.) | 31st March 2024 (in cr.) | 31st March 2023 (in cr.) |
| Assets | 181.30 | 128.00 | 111.55 |
| Revenue | 120.46 | 66.69 | 113.12 |
| Profit After Tax | 20.52 | 9.66 | 5.82 |
| EBITDA | 32.38 | 15.57 | 12.66 |
| Net Worth | 80.42 | 21.03 | 7.37 |
| Reserve and surplus | 40.57 | 5.03 | -4.63 |
| Total Borrowing | 58.35 | 74.56 | 66.39 |
Explanation
Anlon Healthcare Limited’s revenue increased by 81% from ₹66.69 crores in March 2024 to ₹120.46 crores in March 2025. Moreover, the company’s PAT rose by 112% from ₹9.66 crores to ₹20.52 crores.
Technical Indicators
Several technical indicators are available to assess a company’s potential to deliver returns. Use the parameters mentioned below to analyse the technical aspects of Anlon Healthcare.
| Key Indicators | Value |
| PE Ratio (Price-to-Earnings) | 17.67 |
| EPS (Earnings Per Share) | 5.15 |
| RoNW | 25.51 |
| ROCE | 21.93 |
| ROE | 40.45 |
| EBITDA Margin | 26.88 |
| Price to Book Value | 4.51 |
| Market Capitalisation | ₹483.68 Cr |
Anlon Healthcare Listing Expectations
Anlon Healthcare: IPO allotment is still pending. However, as per the current GMP or market sentiments, it is appropriate to expect higher listing gains from the share. A jump of 5% in Anlon Healthcare GMP indicates that the estimated listing price per share will be somewhere around Rs 96.
It will provide higher listing gains to investors who applied for this IPO. Also, the financial fundamentals of this business made it the experts’ best recommendations for the long term.
Anlon Healthcare Dates
| IPO Open Date | 26th August 2025 |
| IPO Close Date | 29th August 2025 |
| Allotment | 1st September 2025 |
| Refund Date | 2nd September 2025 |
| IPO Listing Date | 3rd September 2025 |
Note: IPO GMP is volatile based on market sentiment. Hence, one should conduct their research before investing in it.
Recent Articles
Oval Projects Engineering IPO GMP & Review: Apply or Avoid?
Best Stocks to Buy Today: Explore Best Stocks With Expected Trends
Abril Paper Tech IPO GMP & Review: Apply or Avoid?
Snehaa Organics IPO GMP & Review: Apply or Avoid?
Anondita Medicare IPO Subscription Day 2
Related Posts
Striders Impex IPO Listing Preview: What to Expect Now?
Acetech E-Commerce IPO Allotment Status: 0.85x Subscribed, GMP Flat — Check Online
Acetech E-commerce IPO Day 3: Subscription at 0.85x, GMP Flat | Live Updates
Why is Asian Paints’ Share Price Falling?
Highest Dividend Paying Stocks in India
